
In the spring, we will participate in the 1st Czechoslovak Congress of Medical Genetics, which will take place from April 2–4, 2025, at the Cultural and Congress Center Elektra in the spa town of Luha...
Read moreVisit us at the 19th edition of the RANK 2025 conference, which will take place on March 19th and 20th at the Zlatá Štika Hotel in Pardubice. The conference is organized by the Czech Society of Clinic...
Read moreWe would like to invite you to the 23rd Kapras Day on the topic of "Clinical Genetics," which will take place on Wednesday, February 26, 2025, in the Congress Hall of Hotel Olšanka in Prague. We loo...
Read moreAdaptive immune systems from prokaryotes utilize clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR associated (Cas) proteins to cleave foreign genetic material. CasRx, Cas13d from Ruminococcus flavefaciens XPD3002, is highly active and short, 94KD.
The dcas13a is a mutant cas13a. It can bind target RNA and can not cut the RNA.
Applications
Targeted RNA knockdown
RNA editing
Nucleic acid detection
Source
E. coli
Organism
Ruminococcus flavefaciens XPD3002 (CasRx)
Molecule Weight: 94KD
UniProt #
U2PSH1
Purity
> 95 % as determined by SDS-PAGE
Storage
-20 Avoid repeated freeze-thaw cycles.
Cas13 Storage Buffer
0.3 M NaCl, 20 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 1 mM DTT, 50% Glycerol
10X Cas13 Reaction Buffer
200 mM HEPES, 50 mM MgCl2, 1 M NaCl, 1 mM EDTA, pH 6.5
10X Cas13 sherlock reaction buffer (requested)
200 mM HEPES, 90 mM MgCl2, pH 6.8
Name |
Cat# |
Description |
dCas13d |
dCAS13d-100 |
100 μg,1 mg/ml |
dCas13d |
dCAS13d-200 |
1 mg,1 mg/ml |
dCas13d |
dCAS13d-300 |
100 mg,10 mg/ml |